Want to join the conversation?
Don Carson of Susquehanna Financial Group asks about $MON's FY17 outlook. CFO Pierre Courduroux said entering into 2017, $MON believes it has momentum and this momentum will carry into FY18 and FY19 and $MON will have some tailwinds. Intacta's demand is strong in the market and this will be a key growth driver.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?